Fuda Cancer Hospital
| 中国 | トルコ | オーストリア | |
| 大腸癌に対する放射線療法 | から $11,500 | から $7,000 | から $12,000 |
| 乳癌化学療法 | から $14,800 | から $1,200 | から $15,000 |
Dr. Liuying directs the Oncology Ward at Jinshazhou Hospital in Guangzhou. She specializes in minimally invasive ablation for liver, lung, and colorectal cancers. Her primary focus includes hepatocellular carcinoma and melanoma liver metastasis. Dr. Liuying contributed to the national expert consensus on thermal ablation for lung tumors.
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
The China Liver Cancer (CNLC) system defines Stage 2 as an intermediate level of liver cancer. It requires preserved liver function (Child-Pugh A or B). The disease must remain localized to the liver. There is no spread to major vessels, lymph nodes, or distant organs.
Bookimed Expert Insight: Chinese oncology centers often prioritize clinical resectability over traditional TNM staging labels. For example, Dr. Liuying at Jinshazhou Hospital manages cases where liver function impacts the plan more than tumor size. Fuda Cancer Hospital successfully treats Stage 2 cases using minimally invasive cryosurgery. This approach helps patients who cannot tolerate standard chemotherapy or major resection.
Patient Consensus: Patients note that staging labels in China may shift after surgery or biopsy. They emphasize confirming if the cancer is resectable or requires alternative therapies like TACE.
Surgery is a primary curative option for Stage 2 liver cancer in China. National guidelines prioritize surgical resection or transplantation for localized tumors. Chinese specialists use the China Liver Cancer staging system to determine operability. Success depends on liver function and tumor location after thorough scans.
Bookimed Expert Insight: Chinese oncology centers often apply a more aggressive surgical criteria than Western hospitals. Some facilities specialize in treating late-stage cancer for over 30,000 international patients. These centers regularly combine resection with specialized technologies like vascular interventional therapy. This approach allows surgeons to operate on tumors previously considered too risky or inoperable.
Patient Consensus: Patients note that liver health often matters more than the stage label itself. Many emphasize that a hepatobiliary surgeon’s expert opinion is vital before deciding against surgery.
China combines immunotherapy with localized treatments by integrating checkpoint inhibitors with procedures like TACE, cryosurgery, or NanoKnife. This multi-modal strategy turns immune-reactive tumors into hot ones to increase response rates. Centers frequently use hepatic artery infusion and ablation to trigger systemic anti-tumor responses through antigen release.
Bookimed Expert Insight: A distinct pattern in China is the aggressive use of downstaging strategies for stage 2 liver cancer. Clinics like Fuda Cancer Hospital utilize JCI-accredited facilities to combine specialized vascular interventional therapy with immunotherapy. This sequence aims to shrink lesions enough for curative surgery rather than relying purely on systemic drugs. Specialists like Dr. Liuying focus on microwave ablation to reduce tumor burden before starting immunotherapy cycles.
Patient Consensus: Patients note that doctors prioritize stabilizing liver function before starting these intense combinations. They also emphasize that the sequence of local treatment followed by immunotherapy helps manage side effects better.
Traditional Chinese Medicine cannot cure Stage 2 liver cancer on its own. Modern interventions like surgical resection or ablation are required to remove tumors. Chinese oncology centers typically use integrative care. They combine Western surgery with herbal formulas to manage side effects.
Bookimed Expert Insight: High-volume centers like Fuda Cancer Hospital demonstrate that successful outcomes rely on multi-modality approaches. They utilize NanoKnife and cryosurgery alongside supportive therapies for over 30,000 international patients. Choosing a clinic with JCI accreditation ensures that these integrative methods meet strict global safety standards. This is vital because incorrect herbal dosages can cause liver toxicity.
Patient Consensus: Patients note that feeling better from herbs does not always mean the tumor is shrinking. They emphasize tracking progress through CT scans or MRI rather than just physical comfort.